Stock Screener App

Frei - Play StoreApp Store

Installieren Installieren

Dow:

Nasdaq:

S&P 500:

ELVN

$44.580.75%0.33

Nachbörslich: 44.63+0.05 +0.11%

Enliven Therapeutics Inc (ELVN)

Date: O: H: L: C: Vol:

Enliven Therapeutics Inc Aktie (ELVN) Neueste Nachrichten

BlackRock reports sole voting power over 5.1M Enliven Therapeutics (ELVN) shares. - Stock Titan

Form 4 Enliven Therapeutics Inc: Benjamin Hohl (CFO) For: 19 October By Investing.com - Investing.com South Africa

Enliven Therapeutics CMO Collins sells $192,342 in ELVN stock By Investing.com - Investing.com South Africa

Enliven Therapeutics CFO Hohl sells $231,545 in shares - Investing.com

Enliven Therapeutics CFO Hohl sells $231,545 in shares By Investing.com - Investing.com Nigeria

Form 4 Enliven Therapeutics Inc: Helen Louise Collins (CHIEF MEDICAL OFFICER) For: 19 October - Investing.com Nigeria

Enliven Therapeutics CMO Collins sells $192,342 in ELVN stock By Investing.com - Investing.com Nigeria

Form 4 Enliven Therapeutics Inc: Benjamin Hohl (CFO) For: 19 October - Investing.com UK

Medical chief exercises $2.48 options and sells 5,000 shares at Enliven Therapeutics (ELVN). - Stock Titan

Enliven Therapeutics CMO Collins sells $192,342 in ELVN stock - Investing.com

Form 4 Enliven Therapeutics Inc: Helen Louise Collins (CHIEF MEDICAL OFFICER) For: 19 October - Investing.com UK

After exercising options, Enliven Therapeutics (ELVN) CFO sells 6,018 shares under a trading plan. - Stock Titan

Director Helen Collins plans to sell 15,000 Enliven Therapeutics (ELVN) shares. - Stock Titan

Form 4 Enliven Therapeutics Inc: Kristine M. Ball (Director) For: 14 October - Investing.com Nigeria

A 23,394-option grant to director Ball at Enliven Therapeutics (ELVN) carries a $39.28 exercise price. - Stock Titan

Enliven Therapeutics director Scott Garland sells $606k in stock By Investing.com - Investing.com South Africa

Form 4 Enliven Therapeutics Inc For: 12 October By Investing.com - Investing.com Nigeria

Enliven Therapeutics director Scott Garland sells $606k in stock By Investing.com - Investing.com Nigeria

Form 4 Enliven Therapeutics Inc For: 12 October By Investing.com - Investing.com Canada

Enliven Therapeutics director Scott Garland sells $606k in stock - Investing.com

Form 4 Enliven Therapeutics Inc For: 12 October By Investing.com - Investing.com UK

After exercising options at $15.47, Enliven Therapeutics (ELVN) director sells 13,000 shares. - Stock Titan

Director Jeffrey Garland proposes selling 13,000 Enliven Therapeutics (NASDAQ: ELVN) shares. - stocktitan.net

Enliven Therapeutics CFO Benjamin Hohl sells $303,003 in stock By Investing.com - Investing.com South Africa

Enliven Therapeutics CFO Benjamin Hohl sells $303,003 in stock - Investing.com

Enliven Therapeutics CFO Benjamin Hohl sells $303,003 in stock By Investing.com - Investing.com Canada

Enliven Therapeutics (ELVN) CFO exercises options, sells 6,018 shares - Stock Titan

Enliven Therapeutics (Nasdaq:ELVN) - Stock Analysis - Simply Wall Street

Enliven Therapeutics Insider Sold Shares Worth $303,003, According to a Recent SEC Filing - Yahoo Finance

Enliven Therapeutics (ELVN) officer lines up new stock sale - Stock Titan

(ELVN) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight - GlobeNewswire Inc.

Planned stock sale at Enliven Therapeutics (NASDAQ: ELVN) tops the million-dollar mark - Stock Titan

Enliven's Morgan Stanley conference chat will be webcast Sept. 16 - Stock Titan

Enliven Therapeutics to Present at Upcoming Investor Conferences - PR Newswire

Enliven Therapeutics: A Clean Active-Site TKI Could Redefine CML Sequencing (NASDAQ:ELVN) - Seeking Alpha

Enliven Therapeutics to Present at Upcoming Investor Conferences - finance.yahoo.com

Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting - PR Newswire

Enliven will present leukemia drug data twice at a Houston meeting - Stock Titan

Discipline and Rules-Based Execution in ELVN Response - Stock Traders Daily

Enliven Therapeutics Presents ELVN-001 Data at SOHO Annual Meeting - Intellectia AI

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX) - theglobeandmail.com

Enliven Therapeutics Inc. (NASDAQ: ELVN) Share Price, ELVN Stock News, ELVN Share Price & Updates - kalkine.ca

Enliven (ELVN) Earnings Snapshot: EPS Falls Short of Its Estimate in the Reported Period; Share Response: The Stock Records a 0.79% Decrease on the Day - Profit Cycle Analysis - vinanet.vn

Handelsbanken Fonder AB Buys New Shares in Enliven Therapeutics, Inc. $ELVN - MarketBeat

Enliven Therapeutics CFO Benjamin Hohl Executes Two Stock Sales on August 17 Under 10b5-1 Plan - Kalkine Media

Benjamin Hohl Sells 6,018 Shares of Enliven Therapeutics (NASDAQ:ELVN) Stock - MarketBeat

Enliven (NASDAQ: ELVN) CFO sells 6,018 shares in 10b5-1 plan - Stock Titan

Enliven Therapeutics (ELVN) CMO exercises options, sells stock - Stock Titan

Enliven’s Lead Drug Could Disrupt The Leukemia Treatment Market, Analyst Says - Sahm

Ähnlich wie ELVN

CELC$67.122.91%

PBLS$27.273.71%

VKTX$26.821.69%

TARS$73.391.95%